Skip to Main Content
Skip Nav Destination

Characterization of Extrachromosomal DNA During Cancer Progression

November 25, 2024

Major Finding: Extrachromosomal DNA (ecDNA) confers fitness advantages during tumor progression and metastasis.
Approach: ecDNA was assessed across multiple cohorts compiled across disease stage, treatment status, and time.
Impact: This study suggests targeting processes that contribute to ecDNA formation and maintenance as a therapeutic strategy.

You do not currently have access to this content.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal